SLC5A2 and cirrhosis of liver: Based on this preliminary evidence, we hypothesized that SGLT2-Is would have the potential to reduce PH and liver fibrosis progression by rearrangement of the crosstalk between LSECs and HSCs in liver cirrhosis.